Articles with public access mandates - Andrea Visentin, M.D.Learn more
Not available anywhere: 8
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
F Frezzato, F Raggi, V Martini, F Severin, V Trimarco, A Visentin, ...
International journal of cancer 145 (11), 3089-3100, 2019
Mandates: AIRC Foundation for Cancer Research in Italy
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells
V Martini, C Gattazzo, F Frezzato, V Trimarco, M Pizzi, G Chiodin, ...
British journal of haematology 178 (1), 81-93, 2017
Mandates: Government of Italy
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and L yn inhibition by nocodazole
F Frezzato, V Trimarco, V Martini, C Gattazzo, E Ave, A Visentin, ...
British journal of haematology 165 (5), 659-672, 2014
Mandates: Government of Italy
New responsibilities for aged kinases in B‐lymphomas
F Piazza, S Manni, A Arjomand, A Visentin, L Trentin, G Semenzato
Hematological Oncology 38 (1), 3-11, 2020
Mandates: AIRC Foundation for Cancer Research in Italy
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia
A Visentin, C Briani, S Imbergamo, F Frezzato, A Angelini, M Fedrigo, ...
Hematological Oncology, 2017
Mandates: Government of Italy
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia
M Deodato, AM Frustaci, P Sportoletti, L Laurenti, R Murru, A Visentin, ...
Leukemia & Lymphoma 63 (8), 1985-1988, 2022
Mandates: AIRC Foundation for Cancer Research in Italy
A case of “double hit” mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and …
G Scapinello, M Riva, A Branca, M Pizzi, L Bonaldi, A Martines, S Manni, ...
Annals of Hematology 99, 2715-2717, 2020
Mandates: AIRC Foundation for Cancer Research in Italy
Anaemia during venetoclax ramp‐up phase: Do not forget unusual causes
CA Cavarretta, A Visentin, S Pravato, E Piva, F Piazza, D Basso, L Trentin
International Journal of Laboratory Hematology 44 (5), e211-e214, 2022
Mandates: AIRC Foundation for Cancer Research in Italy
Available somewhere: 69
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
P Baliakas, S Jeromin, M Iskas, A Puiggros, K Plevova, F Nguyen-Khac, ...
Blood, The Journal of the American Society of Hematology 133 (11), 1205-1216, 2019
Mandates: Swedish Research Council, Slovenian Research Agency, European Commission …
Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo
L Leanza, M Romio, KA Becker, M Azzolini, L Trentin, A Manago, ...
Cancer cell 31 (4), 516-531. e10, 2017
Mandates: German Research Foundation, Government of Italy
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, ...
Blood, The Journal of the American Society of Hematology 137 (10), 1365-1376, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, German …
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ...
Leukemia 35 (12), 3444-3454, 2021
Mandates: Government of Spain
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy
A Visentin, N Compagno, F Cinetto, S Imbergamo, R Zambello, F Piazza, ...
Haematologica 100 (12), e515, 2015
Mandates: Government of Italy
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival
V Trimarco, E Ave, M Facco, G Chiodin, F Frezzato, V Martini, C Gattazzo, ...
Oncotarget 6 (39), 42130, 2015
Mandates: Government of Italy
In chronic lymphocytic leukemia the JAK2/STAT3 pathway is constitutively activated and its inhibition leads to CLL cell death unaffected by the protective bone marrow …
F Severin, F Frezzato, A Visentin, V Martini, V Trimarco, S Carraro, ...
Cancers 11 (12), 1939, 2019
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
GM Rigolin, E Saccenti, E Guardalben, M Cavallari, L Formigaro, ...
British Journal of Haematology 181 (2), 229-233, 2018
Mandates: Government of Italy
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia
A Visentin, L Bonaldi, GM Rigolin, FR Mauro, A Martines, F Frezzato, ...
British journal of cancer 121 (2), 150-156, 2019
Mandates: Government of Italy
The complex karyotype landscape in chronic lymphocytic leukemia allows to refine the risk of Richter syndrome transformation
A Visentin, L Bonaldi, GM Rigolin, FR Mauro, A Martines, F Frezzato, ...
Haematologica, 2021
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Integrated CLL scoring system, a new and simple index to predict time to treatment and overall survival in patients with chronic lymphocytic leukemia
A Visentin, M Facco, F Frezzato, M Castelli, V Trimarco, V Martini, ...
Clinical Lymphoma Myeloma and Leukemia 15 (10), 612-620. e5, 2015
Mandates: Government of Italy
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs
C Vitale, C Salvetti, V Griggio, M Porrazzo, L Schiattone, G Zamprogna, ...
Blood, The Journal of the American Society of Hematology 137 (25), 3507-3517, 2021
Mandates: AIRC Foundation for Cancer Research in Italy
Publication and funding information is determined automatically by a computer program